Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy

Purpose To assess the clinical utility of the prostate-specific antigen mass ratio (PSA-MR), a newly developed PSA derivative, simply defined as the (i) PSA density (PSA-D) multiplied by the plasma volume or (ii) total PSA amount in circulation per prostate volume, for predicting prostate cancer (P...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Won Ki Lee, Sangchul Lee, Sung Kyu Hong, Sang Eun Lee, Won Suk Choi, Seok-Soo Byun
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Sociedade Brasileira de Urologia 2014-08-01
Saila:	International Brazilian Journal of Urology
Gaiak:	Prostatic Neoplasms Prostate-Specific Antigen Biopsy Mass Screening
Sarrera elektronikoa:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382014000400484&lng=en&tlng=en
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!